✦ LIBER ✦

Preliminary studies of acyclovir in chronic hepatitis B

✍ Scribed by Coleman I. Smith; George H. Scullard; Peter B. Gregory; William S. Robinson; Thomas C. Merigan

Book ID: 115678896
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 444 KB
Volume: 73
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(82)90103-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acyclovir in chronic hepatitis B virus i

Acyclovir in chronic hepatitis B virus infection

✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with acyclovir: Pilot study

✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot

Controlled clinical trial of acyclovir i

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi

ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT

ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT OF INTERFERON IN CHRONIC HEPATITIS B

✍ Schalm, S.W.; Van Buuren, H.R.; Heytink, R.A.; De Man, R.A. 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 450 KB

An open study of human lymphoblastoid in

An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection

✍ Guarascio, Paolo; De Felici, Anna Paola; Migliorini, Daniela; Alexander, Graeme 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Chronic hepatitis B and IL28B rs12979860

Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study

✍ Kandemir, Özlem; Fidancı, Şenay Balcı; Demir, Neslihan; Görür, Ayşegül; Tamer, L 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 193 KB